100717
Patients with a progression-free interval (PFI) of 3–6 months saw substantial benefits from platinum rechallenge.
Collaborating with infrastructure teams to release "language packs" to the community. 2. Medical Research: Platinum-Resistant Ovarian Cancer 100717
Moving existing hard-coded diagnostics into the new system. Patients with a progression-free interval (PFI) of 3–6